Ingrid M. A. de Graaf-de Swart
No más puestos en curso
Origen de la red de primer grado Ingrid M. A. de Graaf-de Swart.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
University of Utrecht
32
| College/University | Other Consumer Services | 32 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Ingrid M. A. de Graaf-de Swart a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| Nyenrode Business Universiteit | College/University | Masters Business Admin Masters Business Admin Graduate Degree Graduate Degree | |
| Maastricht University | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
| Erasmus University Rotterdam | College/University | Masters Business Admin Graduate Degree Masters Business Admin | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| Stichting Steun Alzheimercentrum VUmc | Investment Trusts/Mutual Funds | Corporate Officer/Principal Director/Board Member | |
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Investment Managers | Private Equity Investor Investment Committee Member | |
| University of Amsterdam | College/University | Doctorate Degree Graduate Degree | |
| University Medical Center of Utrecht | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Cito BV
 Cito BV Internet Software/ServicesTechnology Services Part of Stichting Cito Instituut Voor Toetsontwikkeling, Cito BV is a Dutch company that provides tests, exams, tracking systems, certification, and research for both education and organizations. Founded in 1968, the company is based in Arnhem, Netherlands. Cito's new student tracking system, In Beeld, focuses on student growth, while their central exams provide tools and information for teachers, such as Wolf, Mix & Meet, exam reports, and more. The company is committed to providing equal opportunities for everyone. | Internet Software/Services | Chairman Chief Executive Officer | |
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| Vrije Universiteit Amsterdam | College/University | Graduate Degree Corporate Officer/Principal | |
| ABN AMRO BANK N.V. | Major Banks | Compliance Officer Chairman | |
Lead Pharma Holding BV
 Lead Pharma Holding BV Pharmaceuticals: MajorHealth Technology Lead Pharma Holding BV develops small-molecule drugs for the treatment of autoimmune diseases and cancer. It specializes in medicinal, computational, and protein chemistry, x-ray crystallography, cell biology, and integration x-omics. The company was founded by Ad van Gorp, Leon de Windt, and Pieter Doevendans in 2007 and is headquartered in Oss , the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
The Royal Netherlands Academy of Arts & Sciences
 The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Netherlands Academy of Arts & Sciences provides research services in the field of science and art. The private company is based in Amsterdam, Netherlands and has subsidiaries in Netherlands. The CEO of the Dutch company is Wilma de Koning. | Miscellaneous Commercial Services | President Corporate Officer/Principal | |
| HEINEKEN N.V. | Beverages: Alcoholic | Public Communications Contact Corporate Officer/Principal | |
| Hubrecht Organoid Technology Foundation | Corporate Officer/Principal Chairman | ||
| The International Society On Thrombosis & Haemostasis | President | ||
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| AGENUS INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| MINK THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
ACS Biomarker BV
 ACS Biomarker BV Medical SpecialtiesHealth Technology ACS Biomarker BV develops and commercializes cardiovascular biomarkers. The firm offers miRNA profiling services. It engages in the discovery, validation, and commercialization of biomarkers that improve diagnosis, prognosis and management of cardiac diseases. The company was founded in 2007 by Mat J. A. P. Daemen, Yigal M. Pinto and Tilman Hackeng and is headquartered in Maastricht, the Netherlands. | Medical Specialties | Founder | |
| CARIM School for Cardiovascular Diseases | Director/Board Member | ||
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Director/Board Member | |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal | |
Ciclofilin Pharmaceuticals, Inc.
 Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Ciclofilin Pharmaceuticals, Inc. develops cyclophilin inhibitors for infectious, inflammatory and degenerative diseases. It offers antiviral drug development, liver disease, viral co-infection, cyclophilin inhibition, macrocycle chemistry and protein folding. The company was founded in 2014 by Robert T. Foster and is headquartered in San Diego, PA. | Pharmaceuticals: Other | Director/Board Member | |
| HILLSHIRE BRANDS CO | Food: Meat/Fish/Dairy | Public Communications Contact | |
| University of California, Berkeley | College/University | Chief Tech/Sci/R&D Officer | |
| The Medicines Company (Schweiz) GmbH | Corporate Officer/Principal | ||
| HEPION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Chairman | |
| Sara Lee International | Public Communications Contact | ||
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Chairman | |
KBC Securities USA, Inc.
 KBC Securities USA, Inc. Investment Banks/BrokersFinance Founded in 1999, KBC Securities USA, Inc. is a broker/dealer located in New York City. The firm began as the Financial Products group of D. E. Shaw & Co. In 1999, they were purchased by KBC Bank NV. They are a subsidiary of KBC Securities USA, Inc. and their ultimate parent is of KBC Groupe SA (LSE: KBC). KBC Securities is a specialist in annuities, convertible bonds and equity derivatives with a strategic focus on technology. They serve a range of global investors including mutual funds, pension funds, insurance companies, banks, private banks and hedge funds. | Investment Banks/Brokers | Sales & Marketing | |
| University College London | College/University | Graduate Degree | |
| TiasNimbas Business School BV | College/University | Doctorate Degree | |
Atheneos Ventures LLC
 Atheneos Ventures LLC Investment ManagersFinance Atheneos Ventures LLC (Atheneos Ventures) is a venture capital firm founded in 2009. The firm is headquartered in Santa Clara, California. | Investment Managers | Private Equity Investor | |
| University of Tilburg | College/University | Masters Business Admin | |
InteRNA Technologies BV
 InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Organon Biosciences, Inc. | Corporate Officer/Principal | ||
| MERUS N.V. | Biotechnology | Chairman | |
| Glaxo, Inc. | Corporate Officer/Principal | ||
Genmab, Inc.
 Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer |
Estadísticas
Internacional
| Países Bajos | 26 |
| Estados Unidos | 16 |
| Canadá | 4 |
| Reino Unido | 3 |
| Suiza | 3 |
Sectorial
| Health Technology | 17 |
| Consumer Services | 13 |
| Finance | 9 |
| Commercial Services | 4 |
| Consumer Non-Durables | 3 |
Operativa
| Director/Board Member | 88 |
| Corporate Officer/Principal | 67 |
| Graduate Degree | 25 |
| Chairman | 20 |
| Doctorate Degree | 18 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Ingrid M. A. de Graaf-de Swart
- Conexiones Empresas
